SCHEMBL20358212

SCHEMBL20358212

FC(F)(F)c1ccc(-c2cc(-c3ccncc3)cc(-c3ccc(C(F)(F)F)cc3)[n+]2-c2ccncc2)cc1.F[B-](F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 5/20 0.58
▸ NPC1 O15118 6/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ NTSR1 P30989 3/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ UHRF1 Q96T88 1/20 0.41
▸ MAPK13 O15264 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ MAPK12 P53778 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ NR2F2 P24468 1/20 0.37
▸ RAD52 P43351 1/20 0.37
▸ RCE1 Q9Y256 1/20 0.37
▸ GRM2 Q14416 1/20 0.36
▸ ABL1 P00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20365817 0.95 KIF11 (0.63) KIF11NPC1RAB9ANTSR1KDM4E
SCHEMBL20358566 0.84 NPC1 (0.59) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL28652692 0.83 NPC1 (0.57) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL20358292 0.83 NPC1 (0.57) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL20357895 0.83 NPC1 (0.57) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL20358080 0.83 NPC1 (0.57) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL16564290 0.81 NPC1 (0.59) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL28925264 0.80 NPC1 (0.57) NPC1RAB9ANTSR1KDM4EMAPK1
SCHEMBL13410613 0.76 KIF11 (1.00) KIF11MAPK13RAF1MAPK12MAPK11
SCHEMBL931294 0.76 KIF11 (1.00) KIF11MAPK13RAF1MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10563120-B2 Electrochromic compounds and optical articles containing them ESSILOR INTERNATIONAL (FR) 2020-02-18 — — US disclosed
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM ESSILOR INTERNATIONAL (FR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM EYA2, EYA3, ALDH1A2 KIF11 586/4885NPC1 4427/4885RAB9A 1027/4885
US-10563120-B2 Electrochromic compounds and optical articles containing them EYA2, EYA3, ALDH1A2 KIF11 586/4885NPC1 4427/4885RAB9A 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback